Use of genetic instability to predict biochemical recurrence in intermediate-risk prostate cancer

被引：0
|
作者：
Bristow, R. G.
Ishkanian, A. S.
Malloff, C.
Milosevic, M.
Pintilie, M.
van der Kwast, T.
Lam, W.
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
42
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Stratification of patients with intermediate-risk prostate cancer
    Jung, Jin-Woo
    Lee, Jung Keun
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    BJU INTERNATIONAL, 2015, 115 (06) : 907 - 912
  • [22] Radiotherapy in low and intermediate-risk prostate cancer
    Yalman, Deniz
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 86 - 91
  • [23] DNA Copy Number Alterations Independently Predict for Biochemical Recurrence following Radiotherapy in Intermediate Risk Prostate Cancer
    Ishkanian, A. S.
    Malloff, C.
    Meng, A.
    Zafarana, G.
    Albert, M.
    Pintile, M.
    van der Kwast, T.
    Milosevic, M.
    Lam, W.
    Bristow, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S26
  • [24] The baseline recurrence risk of patients with intermediate-risk cervical cancer
    Yoneoka, Yutaka
    Kato, Mayumi Kobayashi
    Tanase, Yasuhito
    Uno, Masaya
    Ishikawa, Mitsuya
    Murakami, Takashi
    Kato, Tomoyasu
    OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (02) : 226 - 233
  • [25] Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence
    So, J.
    Chua, M. L. K.
    Lalonde, E.
    Dal Pra, A.
    Berlin, A.
    Orain, M.
    Hovington, H.
    Bergeron, A.
    Fradet, Y.
    Tetu, B.
    Meng, A.
    Zhang, J.
    Zafarana, G.
    Livingstone, J.
    Pintilie, M.
    van der Kwast, T.
    Fraser, M.
    Boutros, P. C.
    Bristow, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S113 - S113
  • [26] PROGNOSTIC SIGNIFICANCE OF TONSL EXPRESSION AND THE HOMOLOGOUS RECOMBINATION PATHWAY IN INTERMEDIATE-RISK PROSTATE CANCER RECURRENCE
    So, Jonathan
    Chua, Melvin
    Lalonde, Emilie
    Mahamud, Osman
    Berlin, Alejandro
    Dal Pra, Alan
    Orain, Michele
    Hovington, Helene
    Bergeron, Alain
    Fradet, Yves
    Tetu, Bernard
    Meng, Alice
    Zhang, Junyan
    Zafarana, Gaetano
    Pintilie, Melania
    van der Kwast, Theodorus
    Fraser, Michael
    Boutros, Paul
    Bristow, Robert G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S82 - S83
  • [27] Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study
    Oh, Jong Jin
    Park, Seunghyun
    Lee, Sang Eun
    Hong, Sung Kyu
    Lee, Sangchul
    Kim, Tae Jin
    Lee, In Jae
    Ho, Jin-Nyoung
    Yoon, Sungroh
    Byun, Seok-Soo
    ONCOTARGET, 2017, 8 (44) : 75979 - 75988
  • [28] Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database
    Abern, Michael R.
    Aronson, William J.
    Terris, Martha K.
    Kane, Christopher J.
    Presti, Joseph C., Jr.
    Amling, Christopher L.
    Freedland, Stephen J.
    PROSTATE, 2013, 73 (04): : 409 - 417
  • [29] Testosterone Replacement in a Man with Intermediate-risk Prostate Cancer
    Morales, Alvaro
    EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 319 - 320
  • [30] Personalizing the Management of Men with Intermediate-risk Prostate Cancer
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2013, 64 (06) : 903 - 904
12345